Silberstein SD - Search Results

1

Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.

Hutchinson S, Silberstein SD, Blumenfeld AM, Lipton RB, Lu K, Yu SY, Severt L. Hutchinson S, et al. Among authors: silberstein sd. Cephalalgia. 2021 Aug;41(9):979-990. doi: 10.1177/03331024211000311. Epub 2021 Apr 19. Cephalalgia. 2021. PMID: 33874756 Clinical Trial.

2

Inpatient treatment of headache: an evidence-based assessment.

Freitag FG, Lake A 3rd, Lipton R, Cady R, Diamond S, Silberstein S; US Headache Guidelines Consortium, Section on Inpatient Treatment Chairpersons. Freitag FG, et al. Headache. 2004 Apr;44(4):342-60. doi: 10.1111/j.1526-4610.2004.04093.x. Headache. 2004. PMID: 15109359 Free article.

3

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J; Triptan Cardiovascular Safety Expert Panel. Dodick D, et al. Headache. 2004 May;44(5):414-25. doi: 10.1111/j.1526-4610.2004.04078.x. Headache. 2004. PMID: 15147249 Review.

4

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Diamond S, et al. Headache. 2007 Mar;47(3):355-63. doi: 10.1111/j.1526-4610.2006.00631.x. Headache. 2007. PMID: 17371352

5

Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs.

Goldberg J, Wolf A, Silberstein S, Gebeline-Myers C, Hopkins M, Einhorn K, Tolosa JE. Goldberg J, et al. Headache. 2007 Mar;47(3):384-96. doi: 10.1111/j.1526-4610.2006.00441.x. Headache. 2007. PMID: 17371355

6

Cutaneous allodynia in the migraine population.

Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF; American Migraine Prevalence Prevention Advisory Group. Lipton RB, et al. Ann Neurol. 2008 Feb;63(2):148-58. doi: 10.1002/ana.21211. Ann Neurol. 2008. PMID: 18059010 Free PMC article.

7

Prevalence and characteristics of allodynia in headache sufferers: a population study.

Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, Lipton RB; AMPP Group. Bigal ME, et al. Neurology. 2008 Apr 22;70(17):1525-33. doi: 10.1212/01.wnl.0000310645.31020.b1. Neurology. 2008. PMID: 18427069 Free PMC article.

8

Cumulative lifetime migraine incidence in women and men.

Stewart WF, Wood C, Reed ML, Roy J, Lipton RB; AMPP Advisory Group. Stewart WF, et al. Cephalalgia. 2008 Nov;28(11):1170-8. doi: 10.1111/j.1468-2982.2008.01666.x. Epub 2008 Jul 15. Cephalalgia. 2008. PMID: 18644028

9

Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.

Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J. Silberstein S, et al. Headache. 2008 Jul;48(7):1087-95. doi: 10.1111/j.1526-4610.2008.01185.x. Headache. 2008. PMID: 18687081 Review.

10

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.

Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP; Study Group. Cady RK, et al. Headache. 2009 Feb;49(2):216-26. doi: 10.1111/j.1526-4610.2008.01326.x. Headache. 2009. PMID: 19222595 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters